Sanara MedTech Inc. (NASDAQ:SMTI – Free Report) – Equities research analysts at Cantor Fitzgerald decreased their FY2024 EPS estimates for Sanara MedTech in a research note issued on Wednesday, August 14th. Cantor Fitzgerald analyst R. Osborn now anticipates that the company will post earnings of ($2.03) per share for the year, down from their previous forecast of ($0.79). Cantor Fitzgerald has a “Overweight” rating and a $44.00 price objective on the stock. The consensus estimate for Sanara MedTech’s current full-year earnings is ($2.03) per share.
Sanara MedTech Price Performance
Shares of NASDAQ:SMTI opened at $32.25 on Monday. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.80 and a quick ratio of 1.49. Sanara MedTech has a 1-year low of $26.00 and a 1-year high of $43.25. The company has a market capitalization of $282.19 million, a P/E ratio of -54.66 and a beta of 1.59. The firm’s 50 day simple moving average is $29.57 and its two-hundred day simple moving average is $32.66.
Hedge Funds Weigh In On Sanara MedTech
About Sanara MedTech
Sanara MedTech Inc, a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns; and HYCOL, a medical hydrolysate of Type I bovine collagen intended for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers.
Featured Articles
- Five stocks we like better than Sanara MedTech
- How to Use the MarketBeat Dividend Calculator
- Columbia Sportswear: A Turnaround Story That’s Gaining Ground
- How to Most Effectively Use the MarketBeat Earnings Screener
- Lowe’s Stock: Hold Now, Buy it When it Dips
- How to Calculate Inflation Rate
- ZIM Shipping Stock Soars as the Industry Shows a Bottoming Trend
Receive News & Ratings for Sanara MedTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanara MedTech and related companies with MarketBeat.com's FREE daily email newsletter.